Top Results For: Pfizer vaccine 12%

The COVID-19 vaccine's development happened at warp speed, yet experts agree the listed ingredients in the Pfizer shot are pretty standard.

More than 6,000 Canadians have reported contracting COVID-19 and 53 people have died after receiving one vaccine dose, according to the Public Health Agency of Canada (PHAC).

Two studies focused on the vaccine's usage in Israel and Qatar found that Pfizer's shot gave near total protection from the worst possible outcomes of contracting COVID-19.

The formulation of the COVID-19 vaccine for children and adults is the same but the dosage and presentation are different, Pfizer says.

Health Canada has reassured that Pfizer's COVID-19 vaccines 'continue to be safe and effective at protecting against COVID-19,' despite this very rare risk. 

They are also in talks to test a vaccine modified to protect specifically against the highly transmissible new variant first found in South Africa.

Some Canadian parents desperate to get their children vaccinated are taking them to the U.S., where the Pfizer vaccine was approved for use in kids aged five to 11 on Nov. 2.

Pfizer hopes that vaccinations of the group could begin before the next school year, Pfizer's chairman and chief executive, said in a statement.

Health Canada's approval on increasing the dosing on Pfizer's COVID-19 vaccine label has collided with two key concerns: securing the proper equipment and training vaccinators.

The trial, which is being conducted in four countries including the United States, has enrolled more than 37,000 participants.

Pfizer Inc. said it is testing a three-dose course of the COVID-19 vaccine in all age groups under 16, including two to four-year-olds.

The study, which was published in the New England Journal of Medicine, reiterated that one shot of the vaccines isn’t enough for high protection.

Pfizer and German partner BioNTech SE said they have begun delivering doses of their coronavirus vaccine candidates for human testing in the U.S. Trials in Germany had already begun.

Pfizer cautioned the initial protection rate might change by the time the study ends. Even revealing such early data is highly unusual.

Although Pfizer's coronavirus vaccine data looks promising, experts say we should remain 'cautious' as the full data has still not been released.

Pfizer's vaccine is currently authorized to be taken 21 days apart.

Both Pfizer and Moderna jabs have been given the full stamp of approval for use in teens in what's 'a testament to the vaccine's efficacy and safety profile.'

It comes days after the drugmaker announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Canada is set to begin receiving more than two million doses of the Pfizer-BioNTech vaccine each week.

Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for initial COVID-19 vaccine doses and boosters.